Ann: 2023 Results webinar, page-38

First 38 Last

Share
Profile

Follow
In4apenny

864 Posts.

1613

01/03/24

08:24

Post #: 72685138
Share

Originally posted by Guzz: ↑

love to hear everyone's views - but also love how it seems the majority of regular posters here on the forum took the time to actually go through the presentation and come up with their own opinions.

From experience there are a LOT of investors in HC whom wouldnt even know what product their company is spruiking !!

I agree with some comments that Jon seemed strained. Now, I temper that with - for those that have seen previous Jon presentations before - the dude is an absolute "Ice Bath" when it comes to CEO's !!

To further clarify, although a CEO Jon is a medical person first and foremost. To me, it was clear his frustration was aimed at everything non-medical - Culper, asking of dividends, partnerships, SP action, milestone payments. To me, those financial angles were the ones causing him the strain and frustration.

For those on the call I was the one whom asked the question whether NNZ2591 could possibly relate in the future to Chromosome 18q- conditions. When he read that question his voice picked up, murmured "great question" and responded with "at this stage we have gone with the indications which we believe have the greatest application - however we will consider others as opportunity arises over time" (or something to that effect).

He ultimately kept coming back to his previous line of "let the science prove the value". The guy - although a CEO - is clearly not as engaged with the finance aspects of the company as much as the science and getting the best outcome for the drug, patients and carers...which in his mind will ultimately reward stakeholders.

I applaud the approach, which - 100% ethical - means the board and Jon avoid all the other dubious practices we see Executives, CEO's and boards do in relation to finance, CR's, etc on the ASX.

This brings me to my last point - based on all of the above, I just cant see how Jon would entertain a takeover or partnership unless it advances the drug in either time-to-market, success or scale. There is just no way - IMO - he would do a deal purely to get a good price.

Again, all the above is IMO - but its a solid reason(s) why this company is on the way to greatness.

Sometimes its good to have someone at the helm whom isnt prioritising returns !!

Expand

Notwithstanding JP's science background, he is also a chartered accountant, so he also has a finance focus.

NEU Price at posting: $19.36 Sentiment: Buy Disclosure: Held
26 Upvote

0 Great analysis

Reply

Top Stories

GMD

Genesis set for higher gold production in FY25 and earlier mill start

RDN

Raiden Resources jumps 11% as Andover South drilling to kick off with PoW on Minister's desk

ASX

ASX explains: How 'futures' are predicted

TAT

Tartana Minerals firms up producer status with recent 150tn shipment of copper sulphate to the NT

Is the ASX getting its groove back? Here's 5 IPOs in September to watch

There are more pages in this discussion • 93 more messages in this thread...

First 38 Last

Add NEU (ASX) to my watchlist

(20min delay)
Last $14.47		Change -1.120(7.18%)		Mkt cap ! $1.849B

Open	High	Low	Value	Volume
$15.38	$15.40	$14.40	$9.160M	624.9K

Buyers (Bids)

No.	Vol.	Price($)
1	50	$14.46

Sellers (Offers)

Price($)	Vol.	No.
$14.55	1764	2

View Market Depth

No.	Vol.	Price($)
1	50	14.460
2	2041	14.450
3	8114	14.440
1	1732	14.430
1	400	14.420

Price($)	Vol.	No.
14.550	1764	2
14.610	2314	3
14.670	2041	1
14.690	1200	1
14.700	1983	1

Last trade - 16.10pm 02/09/2024 (20 minute delay)

NEU (ASX) Chart

Ann: 2023 Results webinar, page-38

Genesis set for higher gold production in FY25 and earlier mill start

Raiden Resources jumps 11% as Andover South drilling to kick off with PoW on Minister's desk

ASX explains: How 'futures' are predicted

Tartana Minerals firms up producer status with recent 150tn shipment of copper sulphate to the NT

Is the ASX getting its groove back? Here's 5 IPOs in September to watch

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: 2023 Results webinar, page-38

Top Stories

Genesis set for higher gold production in FY25 and earlier mill start

Raiden Resources jumps 11% as Andover South drilling to kick off with PoW on Minister's desk

ASX explains: How 'futures' are predicted

Tartana Minerals firms up producer status with recent 150tn shipment of copper sulphate to the NT

Is the ASX getting its groove back? Here's 5 IPOs in September to watch

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News